Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer

PURPOSE: EGFR mutation is a predictor of epidermal growth factor receptor–tyrosine kinase inhibitor treatment response in patients with non–small-cell lung cancer (NSCLC). However, it remains unclear whether chemotherapy affects EGFR mutation status in NSCLC. We investigated the influence of chemoth...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Bai, Hua, Wang, Zhijie, Chen, Keneng, Zhao, Jun, Lee, J. Jack, Wang, Shuhang, Zhou, Qinghua, Zhuo, Minglei, Mao, Li, An, Tongtong, Duan, Jianchun, Yang, Lu, Wu, Meina, Liang, Zhen, Wang, Yuyan, Kang, Xiaozheng, Wang, Jie
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2012
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321076/
https://ncbi.nlm.nih.gov/pubmed/22826274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.3744
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares